David G. Smith

发表

6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

A. Naylor, A. Takle, J. Witherington, 2003, Bioorganic & medicinal chemistry letters.

Pyridone derivatives as potent and selective VLA-4 integrin antagonists.

N. Parr, A. Naylor, A. Takle, 2006, Bioorganic & medicinal chemistry letters.

Synthesis of BRL 55834 - a novel, potent airways-selective potassium channel activator

D. Eggleston, J. Tedder, D. Buckle, 1992 .

Inhibition of Cyclic Nucleotide Phosphodiesterase by Derivatives of 1, 3‐Bis(cyclopropylmethyl)xanthine.

J. Arch, K. Murray, K. Foster, 2010 .

5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

M. Saunders, J. Liddle, S. Garland, 2003, Bioorganic & medicinal chemistry letters.

Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.

A. Naylor, A. Takle, J. Witherington, 2006, Bioorganic & medicinal chemistry letters.

5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

R. Ife, D. M. Hickey, D. Haigh, 2003, Bioorganic & medicinal chemistry letters.

A hetero Diels-Alder approach to novel thiopyran analogues of aprikalim, A potassium channel activator

D. Buckle, H. Rami, David G. Smith, 1992 .

6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

A. Naylor, A. Takle, J. Witherington, 2003, Bioorganic & Medicinal Chemistry Letters.

Conformational and Steric Modifications of the Pyran Ring of the Potassium-Channel Activator Cromakalim.

D. Eggleston, D. Buckle, S. Readshaw, 1992 .